Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting ligands

Targeting ligands

US Patent 11174481 · Granted Nov 16, 2021

Estimated economic value: $94,991,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
Method to extend ORAN fronthaul specifications to support NBIOT2025
5′-cyclo-phosphonate modified nucleotides2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
Transaminase reactions2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025